VitaNova Life Sciences VNOV Balance Sheet (2017-2026)

OTC VNOV
$1.38 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT
Reported Financials

VitaNova Life Sciences Quarterly Balance Sheet

Periods 36 quarters
Latest Apr 2026

VitaNova Life Sciences reported total assets of $2.45M and total liabilities of $0.40M for the quarter ended Apr 2026, up 8.4% year over year. This balance sheet covers 36 quarters of results from Apr 2017 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Apr2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
0.03M0.04M0.02M0.03M0.04M0.01M0.01M0.81M0.59M0.14M0.22M0.41M0.78M1.05M1.26M1.17M1.60M
Cash & Current Investments
0.03M0.04M0.02M0.03M0.04M0.01M0.01M0.81M0.59M0.14M0.22M0.41M0.78M1.05M1.26M1.17M1.60M
Receivables - NetNet Receivables
0.06M0.05M1.27M1.01M0.88M1.00M0.79M
Receivables - OtherOther Receivables
0.16M0.46M0.38M-0.17M-0.51M0.01M-0.17M
Receivables
0.46M-0.11M0.05M0.75M1.01M0.90M0.83M0.79M
Inventory
0.13M0.21M0.30M0.19M0.04M0.01M0.01M0.13M0.11M
Prepaid Assets
0.01M0.01M0.01M0.00M0.00M0.00M0.01M0.01M0.01M950.00
Current Assets
0.03M0.04M0.02M0.03M0.04M0.01M0.01M0.96M1.19M1.20M1.26M1.32M2.26M2.24M2.34M2.31M2.43M
Non-Current Assets
Land & Improvements
Long-Term Deferred Tax
0.08M0.07M0.10M0.01M0.01M0.03M0.03M0.15M0.16M0.05M0.07M0.08M0.09M0.12M0.15M0.10M0.02M
Other Non-Current Assets
Non-Current Assets
0.02M
Assets
0.03M0.04M0.02M0.03M0.04M0.01M0.01M0.96M1.19M1.20M1.26M1.32M2.26M2.24M2.34M2.31M2.45M
Liabilities
Current Liabilities
Accounts Payables
0.05M0.06M0.07M0.07M0.07M0.07M0.17M0.11M0.21M
Notes Payables
0.01M0.01M0.01M0.01M0.01M0.02M
Payables
0.01M0.01M0.01M0.01M0.01M0.02M0.05M0.06M0.07M0.07M0.07M0.07M0.17M0.11M0.21M
Accumulated Expenses
0.03M0.04M0.04M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.07M0.08M0.08M
Other Accumulated Expenses
0.01M0.00M902.000.00M820.000.00M0.00M
Short term Debt
Current Taxes
0.06M0.07M0.03M0.04M0.29M0.30M0.19M0.27M0.11M
Current Deferred Revenue
0.01M0.00M
Total Current Liabilities
0.03M0.05M0.05M0.06M0.06M0.07M0.07M0.07M0.08M0.09M0.09M0.14M0.20M0.22M0.21M0.35M0.38M0.44M0.46M0.40M
Non-Current Liabilities
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
Total Non-Current Liabilities
Total Liabilities
0.03M0.05M0.05M0.06M0.06M0.07M0.07M0.07M0.08M0.09M0.09M0.14M0.20M0.22M0.21M0.35M0.38M0.44M0.46M0.40M
Shareholder's Equity
Total Debt
0.01M0.01M0.01M0.01M0.01M0.02M
Common Equity
-0.03M-0.02M-0.01M-0.03M-0.03M-0.03M-0.05M-0.06M-0.08M-0.09M0.87M1.06M1.00M1.03M1.11M1.91M1.86M1.90M1.85M2.05M
Liabilities and Shareholders Equity
0.03M0.04M0.02M0.03M0.04M0.01M0.01M0.96M1.19M1.20M1.26M1.32M2.26M2.24M2.34M2.31M2.45M
Retained Earnings
-0.10M-0.08M-0.07M-0.10M-0.10M-0.09M-0.12M-0.12M-0.15M-0.16M1.00M1.01M1.01M1.01M1.01M1.03M1.01M1.01M1.03M1.03M